AlphaLife Sciences Invited to Attend the AI in Pharma Annual Conference | October 4-5 in Boston

The 2023 AI in Pharma Conference, on October 4-5 in Boston, focuses on AI applications and challenges in drug discovery and clinical trials.
Sep 27, 2023 Read More

AlphaLife Sciences Invited to Attend SAPA Annual Meeting | September 29-30 in New Jersey

Join the 2023 SAPA Annual Meeting on September 29-30 in New Jersey, sponsored by AlphaPrime Life Sciences, to explore innovation in pharmaceuticals.
Sep 27, 2023 Read More

How AlphaLife uses AI automation to modernize the life sciences industry

AI's ability to analyze vast data can transform scientific research. AlphaPrime develops SaaS products that enhance clinical trials with AI.
Jul 18, 2023 Read More

Connecting with OpenAI, AlphaLife Sciences Opens ChatGPT Function for Digitalization in Clinical Trials

AlphaPrime integrates its AuroraPrime platform with OpenAI, enhancing clinical research with ChatGPT and exploring AGI applications in drug development.
May 09, 2023 Read More

AlphaLife: Using AI to turbocharge clinical trial processes

Sharon Chen, CEO of AlphaLife, leads a health tech firm developing SaaS solutions for clinical trials, enhancing efficiency with AI and big data.
Apr 14, 2023 Read More

AlphaLife Sciences Collaborates with CSPC to Explore Enterprise-level Intelligent Medical Writing System

On March 30, 2023, AlphaPrime and CSPC launched AuroraPrime Create, an intelligent system for efficient clinical research document generation.
Mar 30, 2023 Read More

AlphaLife CEO, Ms. Xiao Chen, Selected as One of Forbes China's Top 20 Promising Businesswomen in 2023

AlphaPrime's CEO, Sharon Chen, was named one of Forbes China's Top 20 Promising Businesswomen for 2023, recognizing her significant contributions
Mar 10, 2023 Read More

AlphaLife Sciences Completes Tens of Millions of Dollars in A+ Round Financing, Empowering Digitalization of Life Science Clinical Research

On October 12, 2022, AlphaPrime Life Sciences completed A+ round financing of tens of millions, led by Han Kang Capital and advised by Huaxing Capital.
Oct 12, 2022 Read More

Product Launch: With Intelligent Content Recommendations, Prime Create 2.0 Clinical Research Document Generation System Is Online

On August 17, 2022, AlphaPrime announced updates to AuroraPrime Create 2.0, enhancing clinical document generation with smart features.
Aug 17, 2022 Read More

AlphaLife Sciences Completes RMB 100 Million A Round Financing

On July 22, 2021, AlphaPrime Life Sciences completed its RMB 100M A round financing with Lightspeed China, Hankang, and others.
Jul 22, 2021 Read More